Immediate Impact
1 by Nobel laureates 8 from Science/Nature 62 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Nedjad Losic being referenced
First-in-human, dose-escalation, phase (ph) I trial to evaluate safety of anti-Axl antibody-drug conjugate (ADC) enapotamab vedotin (EnaV) in solid tumors.
2019
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nedjad Losic | 281 | 539 | 544 | 300 | 23 | 856 | |
| Guiyuan Lei | 339 | 472 | 503 | 224 | 28 | 876 | |
| Heather Horne | 349 | 220 | 400 | 191 | 30 | 779 | |
| Myriam Mendila | 145 | 753 | 733 | 383 | 16 | 917 | |
| Eddie Hu | 368 | 222 | 543 | 336 | 22 | 1.0k | |
| Paul Moreton | 104 | 694 | 634 | 420 | 21 | 853 | |
| Mehmet F. Fer | 404 | 305 | 313 | 312 | 22 | 1.1k | |
| Matthew Ku | 494 | 251 | 502 | 175 | 46 | 770 | |
| Daniel C. Scullin | 581 | 358 | 642 | 182 | 23 | 1.0k | |
| Sergey Krysov | 169 | 662 | 532 | 472 | 25 | 1.0k | |
| Daniela Gottardi | 191 | 598 | 378 | 405 | 19 | 1.0k |
All Works
Loading papers...